Isomorphic Labs secures over $2 billion in funding to advance AI drug discovery

economictimes.indiatimes.com

Isomorphic Labs, Alphabet's AI drug discovery firm, is nearing a $2 billion funding round led by Thrive Capital. The investment aims to enhance its drug design engine and support global expansion, reflecting Alphabet's strategy to commercialize AI ventures. The company, spun out of Google DeepMind, has partnered with major pharmaceutical firms like Johnson & Johnson and Eli Lilly.


With a significance score of 4, this news ranks in the top 5.4% of today's 33228 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: